Market Cap (In DKK)
640.18 Million
Revenue (In DKK)
30.95 Million
Net Income (In DKK)
-56.32 Million
Avg. Volume
313.08 Thousand
- Currency
- DKK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.21-2.85
- PE
- -8.76
- EPS
- -0.17
- Beta Value
- 1.146
- ISIN
- DK0011048619
- CUSIP
- -
- CIK
- -
- Shares
- 429657000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Peter Moerch Eriksen B.B.A., BBA
- Employee Count
- -
- Website
- https://bioporto.com
- Ipo Date
- 2000-01-13
- Details
- BioPorto A/S, an in-vitro diagnostics company, provides biomarker tests and tools, and antibodies for clinicians and researchers in Europe, North America, Asia, and internationally. It offers the neutrophil gelatinase-associated lipocalin test, a quantitative particle-enhanced turbidimetric immunoassay designed to run on automated chemistry analyzers; monoclonal antibodies for scientific, pharmaceutical, and clinical research; and enzyme-linked immunosorbent assay kits, as well as generic rapid assay device for custom lateral flow assays. The company was incorporated in 1917 and is based in Hellerup, Denmark.
More Stocks
-
GVKPIL
-
WDBG
-
RPM
-
GAMA
-
NVG
-
SWRNASESwarna Securities Limited
SWRNASE
-
MORARKFIMorarka Finance Limited
MORARKFI
-
WONDF